Tristetraprolin: a weapon against HPV-induced cervical cancer?
Gallouzi
Imed-Eddine
IE
McGill University, Department of Biochemistry, Rosalind and Morris Goodman Cancer Center, Montreal, Quebec, Canada. imed.gallouzi@mcgill.ca
Di Marco
Sergio
S
D017209:Apoptosis / Q000502:physiology; D016922:Cellular Senescence / Q000502:physiology; D005260:Female; D052162:Human papillomavirus 16; D052161:Human papillomavirus 18; D006801:Humans; D051816:Tristetraprolin / Q000627:therapeutic use*; D044767:Ubiquitin-Protein Ligases / Q000502:physiology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000821:virology*
D051816:Tristetraprolin; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases